People

Governance Verdict — B

A new CEO one year in, a deeply-aligned 8.8% holder buying every dip, and a credentialed board that is genuinely independent. The single red flag is what came after Jeremy Thigpen handed over the CEO chair in 2025: he kept $2.2M of base salary, $3.7M of fresh stock, and $7.1M of total pay for a non-executive Chair role, while officers were net sellers into a $3–7 share price.

The People Running This Company

Keelan Adamson — President & CEO since April 2025. A 25-year Transocean lifer who climbed through Engineering, HSE, and Operations before becoming COO in 2018 and President in 2022. He has carried the Q4 2024 and FY2025 calls credibly: focused on backlog conversion, fleet utilization, and the announced Valaris merger. The succession was internal, telegraphed, and orderly — the strongest endorsement of bench depth.

Jeremy Thigpen — Executive Chair, former CEO (2015–2025). Took the CEO seat with no prior Transocean tenure (was CFO at NOV) and ran the company through bankruptcy-adjacent restructurings, the dayrate trough, the Songa acquisition, and back into a $6.1B backlog cycle. The retention as Executive Chair — not non-executive — is the governance asterisk: he is still paid like a senior officer.

Thaddeus Vayda — CFO. New to the seat in 2025. Inherited $5.7B of debt and a $2.9B FY2025 net loss, executed a registered share offering in September 2025 that was anchored by Perestroika.

Roderick Mackenzie — Chief Commercial Officer. Books the backlog. Also the most consistent open-market seller in the C-suite (≥10 small sales over 18 months, see below).

What They Get Paid

The Compensation Committee asked shareholders to authorize a $26M cap on FY2027 executive pay; FY2025 actual was $21.5M against the same cap. Nothing about the magnitude is unusual for an offshore driller — what is unusual is the split.

The Thigpen problem. As Executive Chair he received a $2.185M salary — more than the active CEO's $933K (Adamson was paid CEO salary only from April onward). He also took fresh stock awards of $3.7M and a $776K cash incentive. The proxy structures the Executive Chair seat as if it were still a C-suite operating role; for outside shareholders this is roughly a $5M annual transition tax for the privilege of having the former CEO sit in the chairmanship.

Otherwise reasonable. 64–80% of every other NEO's package is variable. Long-term incentives are tied to relative total shareholder return versus a peer group and Free Cash Flow generation. There is a clawback, a 6× base-salary ownership requirement for the CEO and Executive Chair, no single-trigger change-in-control, no severance gross-ups, and Pay Governance LLC advises the committee independently.

Are They Aligned?

This section is the most important one in the deck, because it contains the clearest single fact of the entire governance review: one director is buying every share he can get his hands on, while everyone else trims into vestings.

Ownership map

Mohn's Perestroika is roughly 30× larger than all of management's holdings combined. Operating-officer ownership is in the low single basis points of the float — meaningful in dollars per individual, immaterial as a control bloc.

Insider buying versus selling

Director-shareholder Frederik Mohn (Perestroika) has placed five separate purchases over 24 months — 2.0M at $6.01, 2.0M at $5.23, 1.5M at $4.13, 4.0M at $3.05 (in the September 2025 registered offering), and 1.5M at $4.02. Average purchase price ~$4.50. With the stock at $6.37 today, every block is now in the money. This is the single most credible vote of confidence in the share price by anyone inside the building.

Officers, by contrast, were net sellers. CCO Mackenzie sold ten lots of $22–53K shares between November 2024 and March 2026. CLO Long sold 97K shares at $4.00 (October 2025), 99K + 16K at $5.00 (January 2026), and 82K at $7.45 (May 2026). CEO Adamson sold 41K at $4.00 (October 2025), 66K at $4.50 (December 2025), and 82K at $5.00 (January 2026). Then-CEO Thigpen executed a single 500,000-share sale at $4.32 on November 26, 2025 — just two days before Perestroika's next $4.02 purchase block.

That said, most of the year's "dispositions" by officers are F-code tax-withholding sales tied to RSU vesting, not discretionary exits. The discretionary "S" sales above are the ones that matter, and they are smaller than they look — about $14M combined across all officers over 18 months, against $59M+ of net buying by Mohn.

Dilution

The September 2025 registered share offering is the elephant in the room. Total shares outstanding stand at 1,106.8M; Perestroika alone absorbed 4.0M of the new issuance for $12.2M. The capital raise was used to bridge the Valaris deal and the FY2025 cash burn ($2.9B net loss), and was priced at the worst absolute share price in five years. Heavy dilution at a trough valuation is the most expensive form of capital raise; that is what happened here.

Related-party behavior

Mohn / Perestroika is responsible for essentially all related-party activity. The board has reviewed each and disclosed them properly:

(1) The Songa acquisition (2018) brought Mohn $355M of exchangeable bonds, refinanced in 2020 into 2027 Exchangeable Bonds. (2) In 2023 Transocean repurchased Perestroika's 13.33% interest in the Liquila/Deepwater Aquila JV for ~$16.4M of stock. (3) Perestroika participated in the September 2025 registered offering. (4) Perestroika owns 5.4% of Scana ASA, a Norwegian supplier from which Transocean buys rig parts.

Each is real, none is hidden, and the Audit Committee's policy framework is conventional. The risk is concentration, not concealment: a single 8.8% holder is also the company's most recurring counterparty.

Capital allocation behavior

No dividends. No buybacks. No share repurchases of any size. All cash has been routed to debt service, fleet investment, and the Valaris transaction. Given a net debt / EBITDA ratio that is unfavorable (EBITDA is negative this year), this is the right priority order, but it also means there is no shareholder-yield tool available to absorb the dilution shock.

Skin in the game

Why 7 and not higher: Perestroika's 8.8% stake plus 13M shares of recent buying is exceptional and would justify 9+ on its own. Why not lower: operating-officer ownership is thin, and the new-CEO/Executive-Chair pair are net sellers of stock in the same year Perestroika is net buyer. The score is a weighted average of two very different alignment stories sharing one boardroom.

Board Quality

Eleven directors. Nine declared independent under NYSE rules (Adamson and Thigpen are not). The Lead Independent Director is Chadwick Deaton (former Baker Hughes CEO), who chairs executive sessions and is the channel between the Executive Chair and the independents.

What the matrix says.

Independence is real, not formal: six of the nine independents have run an operating business (Deaton at Baker Hughes, Curado at Embraer and Ultrapar, Dell'Osso at Expand Energy/Chesapeake, Lacey at Woodward, etc.). Three independent directors (Barker ex-PwC UK Vice Chair, Chang, Lacey) qualify as audit committee financial experts; the Audit Committee has four "experts" total, which is above the NYSE standard of one.

The activist DNA is intentional. Intrieri and Merksamer both came from Carl Icahn's investment platform (Icahn Capital, 2008–2016). Icahn was once Transocean's largest activist holder; these two directors are the legacy of that campaign and they bring shareholder-rights muscle that most boards lack. Merksamer is now at Mubadala Capital; Intrieri at his own VDA Capital.

Tenure is long. Five of the eleven directors have served 12+ years (Barker, Chang, Deaton, Curado, Intrieri). Refresh has happened — Adamson, Lacey (2025) and Dell'Osso (2023) are the newer additions — but the median tenure is roughly a decade. For a cyclical capital-intensive business this is a feature; for board challenge it can be a bug.

The two structural concerns. First, the Executive Chair role is filled by the former CEO at fully-paid executive comp, which mutes the Chair's traditional check-and-balance function. Second, Lead Independent Director Deaton is 73 and has served 14 years — at some point the Lead Independent role itself needs refresh.

The Verdict

Grade: B.

Strongest positives. A board with real independence, real domain expertise, and real activist DNA. An 8.8% director-shareholder who has bought 13 million additional shares — at every price between $3 and $6 — over the last 24 months. A clean CEO succession executed internally on schedule. A compensation framework with clawback, ownership requirements, and 65–80% variable pay. Committees that are 100% independent and an independent comp consultant.

Real concerns. (1) The Executive Chair seat pays the former CEO like an operating officer — $7.1M last year — and there is no obvious operational deliverable that justifies that against Adamson's $8.8M. (2) Officers were net sellers into a $3–5 trough in the same window Perestroika was buying. (3) The September 2025 share offering diluted shareholders at a likely cycle-low price. (4) Related-party activity is concentrated in a single director-shareholder, and while each transaction has been reviewed and approved, the concentration itself is a structural risk.

The one thing that would change the grade. Upgrade to A− if (a) the Executive Chair role is repriced as non-executive within 12 months or (b) the Valaris deal closes accretively without further dilution. Downgrade to C if officer selling accelerates while Perestroika stops adding, or if a related-party transaction with Mohn entities materially redirects company cash without competitive bidding.